(2E,4E)-13-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]-13-oxotrideca-2,4-dienal

C40H64O2 — CID 101196262

IUPAC(2E,4E)-13-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]-13-oxotrideca-2,4-dienal
SMILESCC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4CC(C(=O)CCCCCCC/C=C/C=C/C=O)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C40H64O2/c1-30(2)17-16-18-31(3)35-22-23-36-34-21-20-33-29-32(24-26-39(33,4)37(34)25-27-40(35,36)5)38(42)19-14-12-10-8-6-7-9-11-13-15-28-41/h9,11,13,15,20,28,30-32,34-37H,6-8,10,12,14,16-19,21-27,29H2,1-5H3/b11-9+,15-13+/t31-,32?,34+,35-,36+,37+,39+,40-/m1/s1
InChIKeyQFWRPETWHZZISZ-WSKRMUOZSA-N
MW576.95 g/mol
LogP11.26
Rot. Bonds16

About (2E,4E)-13-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]-13-oxotrideca-2,4-dienal

(2E,4E)-13-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]-13-oxotrideca-2,4-dienal (PubChem CID 101196262) has the molecular formula C40H64O2 and a molecular weight of 576.95 g/mol. Its IUPAC name is (2E,4E)-13-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]-13-oxotrideca-2,4-dienal.

Molecular Properties

Compound Name(2E,4E)-13-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]-13-oxotrideca-2,4-dienal
PubChem CID101196262
Molecular FormulaC40H64O2
Molecular Weight576.95 g/mol
Exact Mass576.49
IUPAC Name(2E,4E)-13-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]-13-oxotrideca-2,4-dienal
SMILESCC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4CC(C(=O)CCCCCCC/C=C/C=C/C=O)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C40H64O2/c1-30(2)17-16-18-31(3)35-22-23-36-34-21-20-33-29-32(24-26-39(33,4)37(34)25-27-40(35,36)5)38(42)19-14-12-10-8-6-7-9-11-13-15-28-41/h9,11,13,15,20,28,30-32,34-37H,6-8,10,12,14,16-19,21-27,29H2,1-5H3/b11-9+,15-13+/t31-,32?,34+,35-,36+,37+,39+,40-/m1/s1
InChIKeyQFWRPETWHZZISZ-WSKRMUOZSA-N
XLogP11.26
TPSA34.14 Ų
H-Bond Donors
H-Bond Acceptors2
Rotatable Bonds16
Heavy Atoms42
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500576.95
LogP ≤ 511.26
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 102

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'polyene', 'substructure': 'N/A'}

Analyze (2E,4E)-13-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]-13-oxotrideca-2,4-dienal with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2E,4E)-13-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]-13-oxotrideca-2,4-dienal?
The IUPAC name of (2E,4E)-13-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]-13-oxotrideca-2,4-dienal (CID 101196262) is (2E,4E)-13-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]-13-oxotrideca-2,4-dienal.
What is the SMILES notation for (2E,4E)-13-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]-13-oxotrideca-2,4-dienal?
The canonical SMILES for (2E,4E)-13-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]-13-oxotrideca-2,4-dienal is CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4CC(C(=O)CCCCCCC/C=C/C=C/C=O)CC[C@]4(C)[C@H]3CC[C@]12C.
What is the InChIKey of (2E,4E)-13-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]-13-oxotrideca-2,4-dienal?
The InChIKey is QFWRPETWHZZISZ-WSKRMUOZSA-N. The full InChI is InChI=1S/C40H64O2/c1-30(2)17-16-18-31(3)35-22-23-36-34-21-20-33-29-32(24-26-39(33,4)37(34)25-27-40(35,36)5)38(42)19-14-12-10-8-6-7-9-11-13-15-28-41/h9,11,13,15,20,28,30-32,34-37H,6-8,10,12,14,16-19,21-27,29H2,1-5H3/b11-9+,15-13+/t31-,32?,34+,35-,36+,37+,39+,40-/m1/s1.
What are the key properties of (2E,4E)-13-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]-13-oxotrideca-2,4-dienal?
(2E,4E)-13-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]-13-oxotrideca-2,4-dienal has a molecular weight of 576.95 g/mol, XLogP of 11.26, 16 rotatable bonds, 0 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for (2E,4E)-13-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]-13-oxotrideca-2,4-dienal is sourced from PubChem (CID 101196262), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).